期刊文献+

Enhancing effect of ultrasound-mediated microbubble destruction on gene delivery into rat kidney via different administration routes 被引量:1

Enhancing effect of ultrasound-mediated microbubble destruction on gene delivery into rat kidney via different administration routes
下载PDF
导出
摘要 Objective:To investigate the efficiency ofβ-galactosidase gene transfer into rat kidney with ultrasound-mediated microbubble destruction via different injection routes.Methods:A total of 25 Wistar rats were randomly divided into 5 groups.Four groups received a mixture of optison microbubbles(0.2 mL) and lacz plasmids(25μg) injection via renal artery,tail vein,anterior tibial muscle and renal parenchyma,respectively.The control group received a mixture of PBS (xx mL) and lacz plasmids(25μg) via renal artery.Three days after the gene transfer,ultrasound with fixed frequency and power(1 MHz,xxW) was delivered to the kidneys for 3 min.The efficiency of the gene transfer and expression was evaluated on the basis ofβ-galactosidase expression.The side effects of this method were evaluated by immunohistological method. Results:β-galactosidase expression could be observed only in tubules but not in glomeruli and interstitial area.The efficiency of renal artery group was higher than that of tail vein,anterior tibial muscle and renal parenchyma group(P【0.05).Immunohistochemical analysis revealed co-expression ofβ-galactosidase with a roximal tubule marker,megalin,which suggested that ultrasound enhanced gene transfer into the proximal tubular epithelial cells.Noβ-galactosidase expression was observed in the extrarenal organs.There were no evident pathological and biochemical changes after gene transfer.Conclusions:Ultrasound-mediated microbubble destruction can transfer gene into kidney via renal artery,tail vein,anterior tibial muscle and renal parenchyma.Compared with renal artery,administrating microbubbles via tail vein and anterior tibial muscle are more convenient and less vulnerarious. Objective:To investigate the efficiency ofβ-galactosidase gene transfer into rat kidney with ultrasound-mediated microbubble destruction via different injection routes.Methods:A total of 25 Wistar rats were randomly divided into 5 groups.Four groups received a mixture of optison microbubbles(0.2 mL) and lacz plasmids(25μg) injection via renal artery,tail vein,anterior tibial muscle and renal parenchyma,respectively.The control group received a mixture of PBS (xx mL) and lacz plasmids(25μg) via renal artery.Three days after the gene transfer,ultrasound with fixed frequency and power(1 MHz,xxW) was delivered to the kidneys for 3 min.The efficiency of the gene transfer and expression was evaluated on the basis ofβ-galactosidase expression.The side effects of this method were evaluated by immunohistological method. Results:β-galactosidase expression could be observed only in tubules but not in glomeruli and interstitial area.The efficiency of renal artery group was higher than that of tail vein,anterior tibial muscle and renal parenchyma group(P<0.05).Immunohistochemical analysis revealed co-expression ofβ-galactosidase with a roximal tubule marker,megalin,which suggested that ultrasound enhanced gene transfer into the proximal tubular epithelial cells.Noβ-galactosidase expression was observed in the extrarenal organs.There were no evident pathological and biochemical changes after gene transfer.Conclusions:Ultrasound-mediated microbubble destruction can transfer gene into kidney via renal artery,tail vein,anterior tibial muscle and renal parenchyma.Compared with renal artery,administrating microbubbles via tail vein and anterior tibial muscle are more convenient and less vulnerarious.
出处 《Asian Pacific Journal of Tropical Medicine》 SCIE CAS 2012年第7期561-565,共5页 亚太热带医药杂志(英文版)
基金 supports from the Second Xiangya Hospital of Central South University,and the supports from Fund from Hunan Province health science and technology support
关键词 ULTRASOUND MICROBUBBLE RENAL artery Tail VEIN Anterior TIBIAL muscle RENAL PARENCHYMA Ultrasound Microbubble Renal artery Tail vein Anterior tibial muscle Renal parenchyma
  • 相关文献

参考文献28

  • 1Jun-Feng Wang,Chang-Jun Wu,Chun-Mei Zhang,Qian-Yi Qiu,Miao Zheng.Ultrasound-mediated microbubble destruction facilitates gene transfection in rat C6 glioma cells[J]. Molecular Biology Reports . 2009 (6)
  • 2G. Rizzuto,M. Cappelletti,C. Mennuni.Gene electrotransfer results in a high-level transduction of rat skeletal muscle and corrects anemia of renal failure. Human Gene Therapy . 2000
  • 3Lien YHH,Lai LW.Liposome-mediated gene transfer into the tubules. Experimental Nephrology . 1997
  • 4Lipkowitz MS,Hanss B,Tulchin N,et al.Transduction of renal cells in vitro and vivo by adeno-associated virus gene therapy vectors. Journal of the American Society of Nephrology . 1999
  • 5Podell. Biotechnology and Applied Biochemistry . 1999
  • 6Pislaru SV,Pislaru C,Kinnick RR, et al.Optimization of ultrasound-mediated gene transfer:comparison of contrast agents and ultrasound modalities. European Heart Journal . 2003
  • 7Imai E.Gene therapy approach in renal disease in the 21st century,2001.
  • 8Miller DL,Song J.Tumor growth reduction and DNA transfer by cavitation-enhanced high-intensity focused ultrasound in vivo. Journal of Ultrasound in Medicine . 2003
  • 9Taniyama Y,Tachibana K,Hiraoka K,et al.Development of safe and efficient novel nonviral gene transfer using ultrasound: enhancement of transfection efficiency of naked plasmid DNA in skeletal muscle. Gene Therapy . 2002
  • 10Li T,Tachibana K,Kuroki M,et al.Gene transfer with echo-enhanced contrast agents: comparison between Albunex, Optison, and Levovist in mice--initial results. Radiology . 2003

共引文献3

同被引文献50

  • 1潘龙飞,李丽君,余蕾.超声及超声微泡介导基因转染的可行性研究[J].西安交通大学学报(医学版),2012,33(5):661-663. 被引量:5
  • 2史京萍,王建华,李肖蓉,邵力正,张斌,卢春,吴文溪.超声介导自制白蛋白微泡和声诺维对体外报告基因转染效率的比较研究[J].南京医科大学学报(自然科学版),2005,25(6):379-382. 被引量:3
  • 3陈云超,张青萍,LIANG Hai-dong,朱蔚,张超,Martin JK Blomley,LU Qi-long.超声和微泡造影剂介导细胞基因转染的实验研究[J].中华超声影像学杂志,2006,15(11):864-868. 被引量:22
  • 4Ortiz R, Melguizo C, Prados J, et al. New gene therapy strategies for cancer treatment: a review of recent patents [ J]. Recent Pat Anticancer Drug Discov,2012,7(3) : 297-312.
  • 5Martinez T, Wright N, Lopez-Fraga M, et al. Silencing human genetic diseases with oligonucleotide-based therapies [ J ]. Hum Genet,2013,132 (5) : 481-493.
  • 6Southerland KW,Frazier SB, Bowles DE, et al. Gene therapy for the prevention of vein graft disease [ J ]. Transl Res, 2013, 161 (4) : 321-338.
  • 7Evans CH, Ghivizzani SC, Robbins PD. Arthritis gene therapy and its tortuous path into the clinic [J]. Transl Res,2013,161 (4) : 205-216.
  • 8Thomas CE, Ehrhardt A, Kay MA. Progress and problems with the use of viral vectors for gent therapy [ J]. Nat Rev Genet,2003 ( 4) : 346-358.
  • 9Wang W, Li W, Ma N, et al. Non-viral gene delivery methods [J]. Curr Pharm Biotechnol,2013,14 (1) : 46-60.
  • 10Suzuki R, Oda Y, Utoguchi N, et al. Progress in the development of ultrasound-mediated gene delivery systems utilizing nano-and microbubbles [ J ]. Journal of Controlled Release, 2011, 149(1) :36-41.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部